Other OTC - Delayed Quote • USD
Athersys, Inc. (ATHXQ)
At close: May 13 at 3:36 PM EDT
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Total Revenue
80.0000
5,325.0000
5,514.0000
1,432.0000
Operating Expense
41,842.0000
82,334.0000
92,572.0000
79,764.0000
Operating Income
-41,762.0000
-77,009.0000
-87,058.0000
-78,332.0000
Other Income Expense
4,255.0000
4,475.0000
103.0000
-433.0000
Pretax Income
-37,507.0000
-72,534.0000
-86,955.0000
-78,765.0000
Net Income Common Stockholders
-37,507.0000
-72,534.0000
-86,955.0000
-78,765.0000
Diluted NI Available to Com Stockholders
-37,507.0000
-72,534.0000
-86,955.0000
-78,765.0000
Basic EPS
-1.65
-6.07
-9.69
-10.50
Diluted EPS
-1.65
-6.07
-9.69
-10.50
Basic Average Shares
19,826.0000
11,945.0000
8,971.0000
7,499.0000
Diluted Average Shares
19,826.0000
11,945.0000
8,971.0000
7,499.0000
Total Operating Income as Reported
-41,762.0000
-77,009.0000
-87,058.0000
-78,332.0000
Total Expenses
41,842.0000
82,334.0000
92,572.0000
79,764.0000
Net Income from Continuing & Discontinued Operation
-37,507.0000
-72,534.0000
-86,955.0000
-78,765.0000
Normalized Income
-41,704.0000
-76,731.0000
-86,955.0000
-78,765.0000
EBIT
-41,762.0000
-77,009.0000
-87,058.0000
-78,332.0000
EBITDA
-40,752.0000
-75,589.0000
-85,631.0000
-77,442.0000
Reconciled Depreciation
1,010.0000
1,420.0000
1,427.0000
890.0000
Net Income from Continuing Operation Net Minority Interest
-37,507.0000
-72,534.0000
-86,955.0000
-78,765.0000
Total Unusual Items Excluding Goodwill
4,197.0000
4,197.0000
--
--
Total Unusual Items
4,197.0000
4,197.0000
--
--
Normalized EBITDA
-44,949.0000
-79,786.0000
-85,631.0000
-77,442.0000
12/31/2020 - 1/2/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
4593.T Healios K.K.
148.00
-3.90%
NYMXF Nymox Pharmaceutical Corporation
0.3109
+20.97%
6VX.F Healios K.K.
0.8550
-4.47%
BIX0.DU BioInvent International AB
2.1850
0.00%
BOVNF BioInvent International AB (publ)
4.7000
0.00%
ALINT.PA IntegraGen SA
0.6700
-2.90%
PLUR Pluri Inc.
6.22
+9.12%
GON.F Geron Corporation
3.4380
-1.38%
MEOBF Mesoblast Limited
0.7900
0.00%
GLSHQ Gelesis Holdings, Inc.
0.0000
0.00%